432 related articles for article (PubMed ID: 17908955)
21. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.
Pradeep CR; Sunila ES; Kuttan G
Integr Cancer Ther; 2005 Dec; 4(4):315-21. PubMed ID: 16282508
[TBL] [Abstract][Full Text] [Related]
22. Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A.
Detwiller KY; Fernando NT; Segal NH; Ryeom SW; D'Amore PA; Yoon SS
Cancer Res; 2005 Jul; 65(13):5881-9. PubMed ID: 15994966
[TBL] [Abstract][Full Text] [Related]
23. MicroRNAs in tumor angiogenesis.
Wang W; Zhang E; Lin C
Life Sci; 2015 Sep; 136():28-35. PubMed ID: 26144623
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of hypoxia-induced angiogenesis by sodium butyrate, a histone deacetylase inhibitor, through hypoxia-inducible factor-1alpha suppression.
Kim SH; Kim KW; Jeong JW
Oncol Rep; 2007 Apr; 17(4):793-7. PubMed ID: 17342317
[TBL] [Abstract][Full Text] [Related]
25. Relationship of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines.
Blancher C; Moore JW; Talks KL; Houlbrook S; Harris AL
Cancer Res; 2000 Dec; 60(24):7106-13. PubMed ID: 11156418
[TBL] [Abstract][Full Text] [Related]
26. Regulation of angiogenesis by hypoxia: role of the HIF system.
Pugh CW; Ratcliffe PJ
Nat Med; 2003 Jun; 9(6):677-84. PubMed ID: 12778166
[TBL] [Abstract][Full Text] [Related]
27. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.
Petit AM; Rak J; Hung MC; Rockwell P; Goldstein N; Fendly B; Kerbel RS
Am J Pathol; 1997 Dec; 151(6):1523-30. PubMed ID: 9403702
[TBL] [Abstract][Full Text] [Related]
28. A new anti-angiogenic small molecule, G0811, inhibits angiogenesis via targeting hypoxia inducible factor (HIF)-1α signal transduction.
Kim KH; Jung HJ; Kwon HJ
Biochem Biophys Res Commun; 2013 Nov; 441(2):399-404. PubMed ID: 24161739
[TBL] [Abstract][Full Text] [Related]
29. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
30. Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.
Sivridis E; Giatromanolaki A; Gatter KC; Harris AL; Koukourakis MI;
Cancer; 2002 Sep; 95(5):1055-63. PubMed ID: 12209691
[TBL] [Abstract][Full Text] [Related]
31. Hypoxia-inducible factor-1-dependent and -independent regulation of insulin-like growth factor-1-stimulated vascular endothelial growth factor secretion.
Slomiany MG; Rosenzweig SA
J Pharmacol Exp Ther; 2006 Aug; 318(2):666-75. PubMed ID: 16682453
[TBL] [Abstract][Full Text] [Related]
32. Multiple regulatory pathways of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in tumors.
Mukhopadhyay D; Datta K
Semin Cancer Biol; 2004 Apr; 14(2):123-30. PubMed ID: 15018896
[TBL] [Abstract][Full Text] [Related]
33. Hypoxia-activated tumor pathways of angiogenesis and pH regulation independent of anemia in head-and-neck cancer.
Koukourakis MI; Giatromanolaki A; Sivridis E; Pastorek J; Karapantzos I; Gatter KC; Harris AL;
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):67-71. PubMed ID: 15093900
[TBL] [Abstract][Full Text] [Related]
34. Hypoxia-inducible factors: a central link between inflammation and cancer.
Triner D; Shah YM
J Clin Invest; 2016 Oct; 126(10):3689-3698. PubMed ID: 27525434
[TBL] [Abstract][Full Text] [Related]
35. HIF-1α in colorectal carcinoma: review of the literature.
Ioannou M; Paraskeva E; Baxevanidou K; Simos G; Papamichali R; Papacharalambous C; Samara M; Koukoulis G
J BUON; 2015; 20(3):680-9. PubMed ID: 26214618
[TBL] [Abstract][Full Text] [Related]
36. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis.
Hicklin DJ; Ellis LM
J Clin Oncol; 2005 Feb; 23(5):1011-27. PubMed ID: 15585754
[TBL] [Abstract][Full Text] [Related]
37. Identification of novel antiangiogenic anticancer activities of deguelin targeting hypoxia-inducible factor-1 alpha.
Oh SH; Woo JK; Jin Q; Kang HJ; Jeong JW; Kim KW; Hong WK; Lee HY
Int J Cancer; 2008 Jan; 122(1):5-14. PubMed ID: 17764071
[TBL] [Abstract][Full Text] [Related]
38. Cell-permeable hypoxia-inducible factor-1 (HIF-1) antagonists function as tumor radiosensitizers.
Shi M; Guo XT; Shu MG; Chen FL; Li LW
Med Hypotheses; 2007; 69(1):33-5. PubMed ID: 17280792
[TBL] [Abstract][Full Text] [Related]
39. Hypoxia-regulated angiogenic inhibitors.
Messmer-Blust A; An X; Li J
Trends Cardiovasc Med; 2009 Nov; 19(8):252-6. PubMed ID: 20447566
[TBL] [Abstract][Full Text] [Related]
40. Endothelial p70 S6 kinase 1 in regulating tumor angiogenesis.
Liu LZ; Zheng JZ; Wang XR; Jiang BH
Cancer Res; 2008 Oct; 68(19):8183-8. PubMed ID: 18829578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
